MYCL promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway.
Saved in:
| Title: | MYCL promotes the progression of triple‑negative breast cancer by activating the JAK/STAT3 pathway. |
|---|---|
| Authors: | Jiang H; Department of Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China., Li X; Department of Radiology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China., Wang W; Department of Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China., Hu Y; Department of Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China., Ren D; Department of Breast Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China. |
| Source: | Oncology reports [Oncol Rep] 2022 Nov; Vol. 48 (5). Date of Electronic Publication: 2022 Sep 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1791-2431 |
|---|---|
| DOI: | 10.3892/or.2022.8418 |
